Table 3.
Total | Gender | Binary Logistic (Controlling for Age) | ||||
---|---|---|---|---|---|---|
| ||||||
% (N) | Male | Female | AOR a | p value b | CI c | |
| ||||||
Total | 100% (372) | |||||
| ||||||
To best of your understanding, is there a GT available for: | ||||||
Alzheimer’s | ||||||
Yes d | 61.7% (171) | 60.0% (96) | 65.7% (65) | |||
No | 38.3% (106) | 40.0% (64) | 34.3% (34) | |||
| ||||||
Autism | ||||||
Yes | 19.6% (54) | 18.1% (29) | 21.2% (21) | |||
No e | 80.4% (221) | 81.9% (131) | 78.8% (78) | |||
| ||||||
Borderline Personality Disorder | 0.14 | 0.068 | 0.02–1.16 | |||
Yes | 4.0% (11) | 6.3% (10) | 1.0% (1) | |||
No f | 96.0% (264) | 93.7% (149) | 99.0% (98) | |||
| ||||||
Intelligence | ||||||
Yes | 7.6% (21) | 8.8% (14) | 7.1% (7) | |||
Nof | 92.4% (254) | 91.2% (145) | 92.9% (92) | |||
| ||||||
Major Depression | ||||||
Yes | 19.6% (54) | 18.2% (29) | 22.0% (22) | |||
Nof | 80.4% (222) | 81.8% (130) | 78.0% (78) | |||
| ||||||
Obsessive Compulsive Disorder | ||||||
Yes | 9.9% (27) | 11.4% (18) | 8.1% (8) | |||
Nof | 90.1% (247) | 88.6% (140) | 91.9% (91) | |||
| ||||||
Schizophrenia | 0.61 | 0.088 | 0.34–1.07 | |||
Yes | 25.0% (65) | 21.2% (34) | 31.0% (31) | |||
No g | 75.0% (195) | 78.8% (126) | 69.0% (69) | |||
| ||||||
Social Anxiety Disorder | 0.13 | 0.049 | 0.02–0.99 | |||
Yes | 4.7% (13) | 7.5% (12) | 1.0% (1) | |||
Nof | 95.3% (261) | 92.5% (147) | 99.0% (97) | |||
| ||||||
Suicidality | ||||||
Yes | 6.6% (18) | 8.2% (13) | 4.1% (4) | |||
Nof | 93.4% (255) | 91.8% (145) | 95.9% (94) | |||
| ||||||
In the future, will GT have a role in diagnosing: | ||||||
Alzheimer’s | ||||||
Yes | 94.2% (243) | 94.3% (150) | 93.9% (93) | |||
No | 5.8%(15) | 5.7% (9) | 6.1% (6) | |||
| ||||||
Autism | ||||||
Yes | 83.7% (216) | 83.0% (132) | 84.8% (84) | |||
No | 16.3% (42) | 17.0% (27) | 15.2% (15) | |||
| ||||||
Bipolar Disorder | 0.56 | 0.06 | 0.30–1.02 | |||
Yes | 79.2% (205) | 83% (132) | 73% (73) | |||
No | 20.8% (54) | 17% (27) | 27% (27) | |||
| ||||||
Major Depression | 0.63 | 0.094 | 0.37–1.08 | |||
Yes | 68.3% (177) | 72.3% (115) | 62% (62) | |||
No | 31.7% (82) | 27.7% (44) | 38% (38) | |||
| ||||||
Schizophrenia | 0.49 | 0.03 | 0.26–0.93 | |||
Yes | 81.2% (211) | 85% (136) | 75% (75) | |||
No | 18.8% (49) | 15% (24) | 25% (25) |
Adjusted Odds Ratio
P value shown if <0.1
Confidence Interval
A genetic test exists and is used clinically, though not widely.
At time of survey, recent studies had indicated a viable test had been developed. This has since been refuted.
No clinically useful genetic test exists.
Genetic markers have been identified for a subset of patients, though a clinically useful test does not exist.